Clarifying Regulatory & Operational Differences Between Cohort & Individual Patient Programs to Align Program Design with Target Populations

• Unpacking important distinctions between cohort and individual patient regulatory pathways and impact on program design
• Exploring cost and resource considerations, including the need for a CRO, which are required to execute cohort and individual patient programs
• Implementing the obligatory commitments of running a cohort program into the pre-existing company infrastructure

Speakers:

Stephen Smith

Senior Program Director, Oncology & Neurology

Corcept Therapeutics Incorporated